Activation of elements within the FGF21/AMPK/PGC-1α cascade is crucial in regulating mitochondrial energy metabolism and has attracted considerable attention as a potential therapeutic target for addressing metabolic disorders like NAFLD. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.